Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grigg

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|June 2, 2020
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantationDanielle H Robinson, Charlotte F M Hughes, Andrew Grigg
Clinical Lymphoma, Myeloma & Leukemia|January 27, 2023
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed LymphomasSun Loo, Andrew Lim, Sze Ting Lee, et al.
Leukemia & Lymphoma|August 14, 2023
Significant heterogeneity in management of calreticulin-mutated essential thrombocythemia and its progression to myelofibrosis: results of a national surveyAlexandra Murton, Cecily Forsyth, David M Ross, et al.
Leukemia & Lymphoma|May 9, 2008
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemiaSarr Gill, Andrew Grigg, Anoren Grigg, et al.
British Journal of Haematology|June 6, 2003
Delayed-onset neutropenia associated with rituximab therapyKritika Chaiwatanatorn, Newton Lee, Andrew Grigg, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 18, 2015
Novel fibrinogen mutations (Aα17Gly→Cys and Aα381Ser→Phe) occurring with a 312Thr→Ala polymorphism: allelic phase assigned by direct mass measurementStephen O Brennan, Andrew D Laurie, Allison Mo, et al.
Internal Medicine Journal|August 20, 2023
Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programmeAndrew Grigg, Ashvind Prabahran, Vanessa Donati, et al.
Bone Marrow Transplantation|June 16, 2018
Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantationEric Wong, Joanne E Davis, Andrew Grigg, et al.
Medical Mycology Case Reports|May 25, 2026
Oesophageal <i>mucormycosis</i> managed with antifungal therapy alone with PET/CT for monitoring treatment response: a case report and a review of the literatureEthan X Tan, Brennan Collis, Natasha Holmes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phaseAshley P Ng, Patricia Servadei, Annabel Tuckfield, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|June 2, 2020
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantationDanielle H Robinson, Charlotte F M Hughes, Andrew Grigg
Clinical Lymphoma, Myeloma & Leukemia|January 27, 2023
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed LymphomasSun Loo, Andrew Lim, Sze Ting Lee, et al.
Leukemia & Lymphoma|August 14, 2023
Significant heterogeneity in management of calreticulin-mutated essential thrombocythemia and its progression to myelofibrosis: results of a national surveyAlexandra Murton, Cecily Forsyth, David M Ross, et al.
Leukemia & Lymphoma|May 9, 2008
Long-term toxicity of allogeneic stem cell transplantation in fludarabine-refractory chronic lymphocytic leukemiaSarr Gill, Andrew Grigg, Anoren Grigg, et al.
British Journal of Haematology|June 6, 2003
Delayed-onset neutropenia associated with rituximab therapyKritika Chaiwatanatorn, Newton Lee, Andrew Grigg, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 18, 2015
Novel fibrinogen mutations (Aα17Gly→Cys and Aα381Ser→Phe) occurring with a 312Thr→Ala polymorphism: allelic phase assigned by direct mass measurementStephen O Brennan, Andrew D Laurie, Allison Mo, et al.
Internal Medicine Journal|August 20, 2023
Outcome of an elective readmission policy in patients receiving acute myeloid leukaemia consolidation therapy and implications for an outpatient management programmeAndrew Grigg, Ashvind Prabahran, Vanessa Donati, et al.
Bone Marrow Transplantation|June 16, 2018
Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantationEric Wong, Joanne E Davis, Andrew Grigg, et al.
Medical Mycology Case Reports|May 25, 2026
Oesophageal <i>mucormycosis</i> managed with antifungal therapy alone with PET/CT for monitoring treatment response: a case report and a review of the literatureEthan X Tan, Brennan Collis, Natasha Holmes, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 5, 2010
Resolution of platelet function defects with imatinib therapy in a patient with chronic myeloid leukaemia in chronic phaseAshley P Ng, Patricia Servadei, Annabel Tuckfield, et al.
Pageof 14